Entry Rationale
The current price is near the 20-day low support level ($13.25), and since there is considerable upside potential to the 20-day high resistance level ($19.45), we will consider a purchase.
Almonty rises after signing tungsten offtake deal with Sandvik
The stock showed an upward trend on the news that Almonty had signed a tungsten offtake agreement with Sandvik.
The current price is near the 20-day low support level ($13.25), and since there is considerable upside potential to the 20-day high resistance level ($19.45), we will consider a purchase.
If the support line ($13.25) breaks, I will cut losses; if the upside potential to the resistance line of $19.45 remains valid, I will aim for profit-taking.
RSI (14) is at 25.1, placing it in the oversold zone; moving averages are in a bullish alignment (right-ordered), trading volume is 0.81x the 20-day average, and the 7-day volatility (rate of change) recorded -23.3%.
VEEE, LRCX, and AEMD, which were suggested as past similar successful cases, have no basis for direct similarity and should therefore be reviewed solely for reference regarding overall top-tier performance.
At entry, the RSI(14) of 25.1 indicated oversold conditions and was near the support line at $13.25, leading to an expectation of a rebound. However, the actual result was a -10.2% return, resulting in a FAILED rating. The recent 7-day change of -23.3% reflects a deep downtrend, and the trading volume, at 0.81 times the 20-day average, was somewhat weak, which later proved insufficient to fully withstand downward pressure.
Through this review, we will take as a lesson that entering a downward trend (-23.3%) without accompanying volume, even in an oversold zone, carries a high risk of stop-loss. In future trades, we will adjust our entry criteria to be more conservative by strictly verifying whether volume accompanies the trade, rather than relying solely on the price position near a support line.